Crossmark

Neutrophil-to-lymphocyte ratio affects the impact of proton pump inhibitors on efficacy of immune checkpoint inhibitors in patients with non‑small-cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s10147-025-02859-2

Published Online: 2025-09-02

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hori, Tomoki

Yamamoto, Kazuhiro https://orcid.org/0000-0002-7513-6725
Ito, Takefumi

Ikushima, Shigeki

Omura, Tomohiro

Yano, Ikuko
License Information

Text and Data Mining valid from 2025-09-02

Version of Record valid from 2025-09-02
More Information

Article History

Received: 5 March 2025

Accepted: 10 August 2025

First Online: 2 September 2025

Declarations

:

: Tomoki Hori, Kazuhiro Yamamoto, Takefumi Ito, Shigeki Ikushima, Tomohiro Omura, and Ikuko Yano declare no conflict of interest.

: This retrospective study involving human participants was conducted in compliance with the ethical standards of the institutional and national research committees and the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical guidelines. The Ethics Committee of Nara Prefecture General Medical Center approved this study (Approval No. 706). Informed consent was obtained by allowing patients to opt-out of the study at any time by reviewing a summary of the study summary published on the institution’s website.

:

: Consent for publication was obtained from patients using an opt-out approach.

Document is current

Any future updates will be listed below